Julie SmithBeing a mum and having a ten year old daughter I am interested in anything that will be of benefit to her now and in the future, so naturally I was curious about this HPV vaccine programme and the possible benefits for her.
Instead of just listening to all the “hype” over this vaccine I endeavoured to uncover actual facts.  I started with Helen Clark’s speech notes on her announcement of the “$177 million programme” two months ago in May (www.beehive.govt.nz/speech)   In her speech she states “About eight in every ten women who have been sexually active will have HPV at some stage of their life.  Normally there are no symptoms, and in 98 per cent of cases it clears itself.  But in those cases where it doesn’t and isn’t treated, it can lead to pre-cancerous cells which may develop into cervical cancer.”

Firstly I wish to thank Dr Roberts and Helen Petousis-Harris from Ministry of Health and Immunisation Advisory Centre respectively for their replies to my letter (July 16) in which I raised concerns over the HPV vaccination programme being implemented next month.
Open discussion from all sides is what’s needed so parents can make an informed decision.  Due to discussions brought about by my letter I have since discovered via the medical fraternity that no studies or testing have or are being carried out on New Zealand women to ascertain which HPV viruses are present or most common here. As this vaccine was researched and developed in America I am amazed that the government is spending $180 million without first establishing that New Zealand women mirror the American studies. When implementing the meningococcal vaccination programme it had been established our strain was unique to New Zealand.  Perhaps the same may or may not be the case with HPV viruses.

In her letter (31 July) Helen Petousis-Harris from the Immunisation Advisory Centre endeavours to discredit  further information I have gathered  regarding the Gardasil HPV Vaccine.
My concern was that impartial tests by the Ministry of Health have never been carried out on New Zealand women.  In her letter she states women from Auckland and Christchurch participated in clinical trials for this vaccine. My research shows these clinical trials were carried out by MSD NZ (Merck Sharp & Dohme New Zealand) which is an off shoot from parent company Merck & Co who is the company marketing this Gardasil HPV Vaccine.  It is also worthwhile noting that Merck & Co is the company behind the now withdrawn painkiller “Vioxx” due to concerns over its safety.  This company has 27,000 lawsuits against it and has already had to pay out billions in damages.  Patents are also expiring on some of its best selling drugs.  It appears that in the later stages of the development of this vaccine things have been hurried along somewhat.  The Food and Drug Administration of America (FDA) documented that safety had never been proven in 11 and 12 year old girls. 

Published: infonews.co.nz New Zealand's local news community
NEWS  9 July 2008, 10:29AM
CREDIT: Jenese James

Death Rate continues to rise in both US and Euorpe.
Last nights news on Gardasil - a Merck & Co vaccination for girls as young as 9 revealed the side affects of this vaccination for cervical cancer. The side affects they said were minor when studied seriously – sore arms, that’s to be expected the female spokesperson said. She obviously failed to do her research properly as thousands of women now suffer not from a sore arm, but from a paralysis of their arm and in some cases their legs as well.
TV One news also failed to mention the 15 deaths – in fact they never mentioned any deaths,

South Canterbury women aged 17 and 18 will be able to be immunised against genital warts from next Monday.  The Government's HPV (genital warts) Immunisation Programme will be launched with free vaccinations for women born in 1990 and 1991.  Next year, the second phase of the immunisation programme will begin for girls aged 12 to 17 (born 1992 onwards) to protect against the virus which causes most cervical cancers, with vaccinations of this age group to be carried out by South Canterbury District Health Board's public health nurses.

Girls under 16 years of age will need written parental consent to receive the HPV vaccine at school.  The vaccination is expected to save 30 lives a year by preventing Human Papillomavirus, which is thought to cause cervical cancer.  However, according to the Ministry of Health's annual surveillance report of sexually transmitted infections, 90 per cent of genital warts detected were not linked to causing cancer.  The same report showed that of the 732 people that were tested in South Canterbuy last year at the family planning clinic and the Timaru Hospital Sexual Health Clinic, 45 had genital warts and out of 685 tested in 2006, 45 had genital warts.  Genital warts was most common in men aged between 20 and 24 and women aged 15 to 19.  The data was given voluntarily by the sexual health clinics and family planning and did not include statistics from general practitioners.


Aluminum 225mcg 

 Animal and human studies have shown aluminum can cause nerve cell death and that vaccine aluminum adjuvants can allow aluminum to enter the brain, as well as cause inflammation at the injection site leading to chronic joint and muscle pain as well as fatigue.

Sodium Borate "Borax" 35mcg

This is the main ingredient in Boric Acid.  Powdered Boric Acid is often used to kill cockroaches.   Sodium Borate is now listed as a dangerous poison.  Symptons of Sodium Borate poisoning are very similar to many of the side effects being reported with the Gardasil vaccine.

"Borax was added to the Substance of Very High Concern (SVHC) candidate list on 16 December 2010. The SVHC candidlate list is part of the EU Regulations on the Registration, Evaluation, Authorisation and Restriction of Chemicals 2006 (REACH), and the addition was based on the revised classification of Borax as toxic for reproduction category 1B under the CLP Regulations. Substances and mixtures imported into the EU which contain Borax are now required to be labelled with the warnings "May damage fertility" and "May damage the unborn child".[23]"

Janet McMillan writes (February 26) that mothers should not let the hysterical comments from people who do not know enough about research put them off their daughters being protected through the HPV vaccine.

I based my decision not to vaccinate my daughter on Dr Diane Harper's findings.  She was contracted by Merck to head the clinical trials for this vaccine because of her credentials, 20 years of HPV vaccine research and development.  The only hysterical comments surrounding this vaccine are those lauding it as a cervical cancer vaccine.

This is simply not true, says Dr Harper in a Radio NZ interview with Ministry of Health Senior Advisor, Dr Allison Roberts on August 1 2008.   It is a HPV vaccine for four strains of the virus.  Dr Harper said it will be another 20-30 years before researchers can make the claim it is a cervical cancer vaccine, and that parents and young girls need to be aware of this.